10x Genomics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $474.0M | $344.1M | $359.3M | $219.7M | $587.4M | $663.6M | $424.2M | $65.1M |
| Accounts Receivable | $47.0M | $87.9M | $114.8M | $104.2M | $85.3M | $51.2M | $33.4M | $28.1M |
| Inventory | $56.3M | $83.1M | $73.7M | $81.6M | $60.0M | $30.0M | $15.3M | $8.6M |
| Total Current Assets | $684.5M | $584.4M | $596.0M | $635.0M | $747.6M | $774.4M | $480.8M | $106.2M |
| Property, Plant & Equipment | $226.7M | $252.6M | $279.6M | $289.3M | $169.5M | $72.8M | $48.8M | $11.1M |
| Goodwill | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $0 | — | — |
| Intangible Assets (Excl. Goodwill) | $62.3M | $15.7M | $16.6M | $22.9M | $25.4M | $22.4M | $22.4M | $642.0K |
| Total Assets | $1.04B | $918.6M | $965.1M | $1.03B | $1.02B | $929.3M | $605.9M | $124.3M |
| Liabilities | ||||||||
| Accounts Payable | $12.7M | $12.9M | $15.7M | $21.6M | $17.4M | $4.7M | $13.0M | $8.8M |
| Total Current Liabilities | $153.5M | $117.6M | $127.2M | $131.0M | $110.4M | $118.1M | $63.0M | $32.4M |
| Long-Term Debt | — | — | — | — | — | $0 | $19.8M | $25.5M |
| Total Liabilities | $245.0M | $208.5M | $224.1M | $223.2M | $201.3M | $190.3M | $185.8M | $101.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.51B | $-1.47B | $-1.28B | $-1.03B | $-863.3M | $-805.1M | $-262.4M | $-231.1M |
| Total Stockholders' Equity | $796.3M | $710.1M | $741.0M | $805.7M | $817.6M | $739.1M | $420.1M | $-220.0M |